SHG:688319 - Chengdu Olymvax Biopharmaceuticals Inc

Chengdu Olymvax Biopharmaceuti
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2019 Q1	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	105.68M 66.6%	115.65M 9.4%	202.39M 75.0%	53.54M -73.5%	179.17M 234.7%	138.07M -22.9%	176.7M 28.0%	66.87M -62.2%	166.33M 148.7%	119.1M -28.4%	143.82M 20.8%	70.8M -50.8%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	9.8M 289.8%	8.93M -8.8%	8.34M -6.6%	2.9M -65.2%	14.55M 401.4%	9.74M -33.1%	11.87M 22.0%	7.16M -39.7%	9.06M 26.7%	8.85M -2.3%	6.93M -21.8%	5.36M -22.7%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	95.88M 57.4%	106.72M 11.3%	194.04M 81.8%	50.63M -73.9%	164.62M 225.1%	128.33M -22.0%	164.83M 28.4%	59.72M -63.8%	157.26M 163.4%	110.25M -29.9%	136.89M 24.2%	65.44M -52.2%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	77.45M 80.9%	89.24M 15.2%	168.14M 88.4%	61.05M -63.7%	120.98M 98.2%	132.18M 9.3%	172.8M 30.7%	62.57M -63.8%	120.84M 93.1%	139.8M 15.7%	140.79M 0.7%	105.72M -24.9%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	67.65M 67.8%	80.31M 18.7%	159.8M 99.0%	58.15M -63.6%	106.43M 83.0%	122.44M 15.1%	160.92M 31.4%	55.42M -65.6%	111.77M 101.7%	130.95M 17.2%	133.87M 2.2%	100.37M -25.0%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	28.23M 36.9%	26.4M -6.5%	34.25M 29.7%	-7.51M -	58.19M -	5.89M -89.9%	3.91M -33.6%	4.3M 10.0%	45.49M 958.4%	-20.7M -	3.02M -	-34.92M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.35M 107.2%	-	-	-	31.04M -	-	-	-	26.44M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	21.92M 7.2%	35.32M 61.2%	30.29M -14.2%	-6.81M -	37.85M -	9.13M -75.9%	-13.6M -	3.85M -	24.69M 540.8%	1.74M -93.0%	-12.73M -	-26M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.06 7.3%	0.089 48.4%	0.075 -15.8%	-0.017 -	0.093 -	0.022 -75.9%	-0.034 -	0.009 -	0.061 541.1%	0.004 -92.9%	-0.031 -	-0.064 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.06 7.3%	0.089 48.4%	0.075 -15.8%	-0.017 -	0.093 -	0.022 -75.9%	-0.034 -	0.009 -	0.061 541.1%	0.004 -92.9%	-0.031 -	-0.064 -